Latest News

Pharmacists enhance migraine management by providing personalized care, navigating treatment options, and addressing comorbid conditions for better patient outcomes.

Discover how the new PREVENT equations enhance cardiovascular risk assessments, improving patient screenings and prevention strategies for diverse populations.

The vouchers are intended to speed up review times for drugs that could fill key unmet needs for Americans.

Surveys reveal significant misunderstandings among Americans about shared decision-making in childhood vaccinations, highlighting the need for better public education.

Explaining megestrol acetate's dual role in managing symptoms and enhancing treatment efficacy for estrogen receptor–positive breast cancer.

Patients with type 2 diabetes (T2D) who initiated statins experienced reductions in major cardiovascular disease (CVD) and mortality across a spectrum of predicted 10-year risk.

To effectively and safely taper benzodiazepines, withdrawal challenges must be addressed while promoting patient involvement.

Toothpaste tablets revolutionize oral care with eco-friendly, convenient options, while pharmacists guide consumers in making informed choices for dental health.

Gestational diabetes disrupts RNA splicing in the placenta, revealing potential targets for improving pregnancy outcomes.

The guidelines are believed to promote screening adherence by providing women with a more comfortable, accessible, and less stressful testing option.

Federal vaccine recommendations for pediatric patients shift dramatically, reducing routine immunizations from 17 to 11, sparking debate on safety and efficacy.

Intravenous laser irradiation of blood shows promise in lowering triglycerides and improving lipid profiles in patients with dyslipidemia.

The complete response letter (CRL) was issued following regulatory updates provided to Sanofi from the FDA.

Enhanced communication between field representatives and case managers improves medication access for patients with rare diseases.

GoodRx enhances access to semaglutide with affordable cash pricing, revolutionizing obesity treatment and supporting patients in weight management.

There are evolving recommendations for aspirin use, including optimal drug dosages and patient selection for effective cardiovascular prevention.

Tradipitant, a novel NK-1 receptor antagonist, was proven effective at reducing the incidence and severity of nausea and vomiting in individuals with motion sickness.

FDA considers relaxing dietary supplement warning labels, raising concerns about consumer safety and informed decision-making among users.

A severe yet often overlooked coinfection with hepatitis B, hepatitis D progresses rapidly—but new therapies are beginning to reshape a long-limited treatment landscape.